Allergan repays, cancels $1 billion revolver upon asset sale to Teva

By Wendy Van Sickle

Columbus, Ohio, Aug. 4 – Allergan plc fully repaid the amounts outstanding under its $1 billion revolving credit loan and guaranty agreement with JPMorgan Chase Bank, NA as administrative agent on Monday, according to an 8-K filing with the Securities and Exchange Commission.

The agreement, which had a Dec. 22, 2014 maturity, was terminated without penalty in connection with the sale of the company’s global generic business to Teva Pharmaceuticals Industries, Inc.

Allergan is an Irvine, Calif.-based multi-specialty health care company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.